|
ZNF236 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09259999994771E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.214300E-04 |
| Normal-vs-Stage2 |
8.541600E-03 |
| Normal-vs-Stage3 |
4.01390000015489E-07 |
| Normal-vs-Stage4 |
7.82269999999308E-07 |
| Stage1-vs-Stage2 |
8.026800E-01 |
| Stage1-vs-Stage3 |
2.967800E-02 |
| Stage1-vs-Stage4 |
1.246100E-02 |
| Stage2-vs-Stage3 |
2.651400E-01 |
| Stage2-vs-Stage4 |
1.940200E-01 |
| Stage3-vs-Stage4 |
7.594000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.86509999947171E-07 |
| Normal-vs-AfricanAmerican |
2.295900E-02 |
| Normal-vs-Asian |
4.389800E-01 |
| Caucasian-vs-AfricanAmerican |
1.413640E-01 |
| Caucasian-vs-Asian |
7.243700E-03 |
| AfricanAmerican-vs-Asian |
7.318400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7468000002594E-07 |
| Normal-vs-Female |
1.217470E-03 |
| Male-vs-Female |
1.542120E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.213300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.43540000002918E-07 |
| Normal-vs-Age(81-100Yrs) |
5.814400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.763600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.798000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.151000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.770100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.846100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.011000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.471000E-01 |
| Normal-vs-Grade 2 |
2.597700E-03 |
| Normal-vs-Grade 3 |
3.57760000513352E-08 |
| Normal-vs-Grade 4 |
3.5858000013711E-08 |
| Grade 1-vs-Grade 2 |
2.533900E-02 |
| Grade 1-vs-Grade 3 |
1.618690E-04 |
| Grade 1-vs-Grade 4 |
1.72113999999945E-05 |
| Grade 2-vs-Grade 3 |
8.518900E-03 |
| Grade 2-vs-Grade 4 |
3.220200E-04 |
| Grade 3-vs-Grade 4 |
1.113810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.420110E-03 |
| Normal-vs-ccB subtype |
3.32560000004811E-06 |
| ccA subtype-vs-ccB subtype |
2.737900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77380000000649E-05 |
| Normal-vs-N1 |
3.966000E-02 |
| N0-vs-N1 |
9.738400E-01 |
|
|
